COVID-19, Heart Problems and Vaccines Supplemental Information
Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis
August 29, 2022
“Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis,
Conclusion: In this systematic review and meta-analysis, we found that the risk of myocarditis is more than seven fold higher in persons who were infected with the SARS-CoV-2 than in those who received the vaccine.
A Systematic Review and Meta-analysis of the
Association Between SARS-CoV-2 Vaccination and
Myocarditis or Pericarditis
(updated 5-9-2023) Myocarditis and COVID-19 vaccines have been a subject of a great deal of misinformation and disinformation. One the most well known sources of disinformation was the study last October that the Florida Surgeon used to suggest that men aged 18-39 should not receive COVID mRNA vaccines. This was an analysis that had a lot of red flags - for example there were no authors listed as drafting the paper. The paper was not peer reviewed and initially the only way it was available was by a word processing document. Many scientists and others found major problems with how the study was conducted.
Two outside epidemiologists, Drs. Kat Wallace and Jon Laxton and the Tampa Bay Times requested the unreleased drafts through the Freedom of Information Act. Those records tell a dramatic story of how the analysis was manipulated.
I will below post a link from an epidemiologist who goes through and describes how this paper was revised over 6 times. The original data showed that vaccines for each demographic group were either protective or neutral against death.
See this article for more information about vaccines and sudden deaths:
Pediatric Cardiologist talks about myocarditis, COVID-19 and vaccines.
Cardiologist discusses studies of myocarditis, COVID-19 and vaccines.
Cardiologist discusses studies of myocarditis, COVID-19 and vaccines.
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection
UNMC Infectious Diseases specialist James Lawler; MD, MPH discusses analysis by Florida Department of Health (go to 15 minute mark of video).
Dr Lawler is the Executive Director of International Programs and Innovation at the Global Center for Health Security and director of clinical and biodefense research at the National Strategic Research Institute. In 2018, he came to the University of Nebraska Medical Center following a military career in which he served as a Navy Commander and was chief of clinical biodefense research at the Naval Medical Research Center, Fort Detrick, Maryland. He was an attending physician at Walter Reed National Military Medical Center and served White House assignments as Homeland Security Council and National Security Council staff, where he worked on biodefense, pandemic response, and health preparedness. Dr. Lawler has field experience treating Ebola patients in sub-Saharan Africa, and he served as a subject matter expert in the training of Department of Defense medical personnel working with infectious diseases patients.
Epidemiologist from the University of Texas Health Science Center School of Public Health discusses myocarditis and the Florida analysis.
Additional updates from UNMC Infectious Diseases specialist Dr James Lawler:
Background information about Dr Lawler.
He is an infectious disease physician at UNMC.
Dr Lawler served 21 years in the US Navy Medical Corps where he attained the rank of Commander. His field medical experience includes duty for 2 years as Marine infantry battalion surgeon and primary medical officer for a 1000-Marine infantry battalion (2nd Battalion, 8th Marines). He also served at the NATO Role 3 Hospital in Kandahar, Afghanistan. He has been involved in disaster relief operations aboard the hospital ship USNS Comfort. He has treated ebola patients
He is a recognized authority on health system and field management of high-consequence infections and has consulted on the topic for multiple non-governmental organizations, national ministries of health, the World Health Organization, and the US Government. In 2014, he was the principal subject matter expert for the US military’s planning process for West Africa Ebola response (Operation United Assistance), briefing the Chairman, Joint Chiefs, and senior Pentagon officials. He subsequently led efforts standing up the Department of Defense (DoD) Ebola Medical Support Team and served as the team’s principal technical expert.
During the last five years of his military career, Dr. Lawler founded and led the Austere Environments Consortium for Enhanced Sepsis Outcomes (ACESO), an international network developing practical solutions for management of severe infectious diseases in resource-limited settings.
Dr. Lawler served on the White House staff in the Homeland Security Council Biodefense Office during the George W. Bush administration and the National Security Council (NSC) Resilience Directorate under the Obama administration, where he led development and coordination of national policy related to medical and public health preparedness, pandemic and public health emergency response, medical countermeasure R&D, biosurveillance, and clinical care for domestic and international health threats.
James Lawler has held positions as an attending physician in internal medicine and infectious diseases at the Walter Reed National Military Medical Center at Bethesda and as an assistant professor of medicine at the Uniformed Services University of the Health Sciences (USUHS). Dr. Lawler received a Bachelor of Science in Engineering (biomedical engineering) from Duke University and graduated from Georgetown University School of Medicine. He completed his internship and residency at the National Naval Medical Center in Bethesda, MD and fellowship at the DoD National Capital Consortium. He received a Master of Public Health and a Diploma in Tropical Medicine and Travelers’ Health from USUHS.
Dr. Lawler’s has focused on research and national policy related to emerging infectious diseases, biodefense and public health preparedness. CDR Lawler has clinical medicine and research experience in multiple field, humanitarian relief and emerging infectious disease environments, most recently as a World Health Organization clinical consultant in Conakry, Guinea during the West African Ebola virus disease epidemic in May 2014.
In response to the COVID-19 pandemic, Dr. Lawler has made a number of early contributions in research, training, and clinical operations. He assisted in leading a small team that deployed to Yokohama, Japan, to repatriate American citizens quarantined aboard the cruise ship Diamond Princess, coordinated quarantine and isolation care for some of the first cohorts of exposed/infected Americans returned from Wuhan and Yokohama, assisted in standing up the first hospital to conduct a randomized-controlled trial of remdesivir for COVID-19, and characterized environmental contamination related to the care of COVID-19 patients.
James Lawler, MD, MPH is currently on staff as a physician at Nebraska Medicine, is an Associate Professor in the Department of Internal Medicine. He is the Director of the International Programs and Innovation Global Center for Health Security and Director of Clinical and Biodefense Research.
Health and Medical Resources: COVID-19
Comments